• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Healthcare Regulatory Affairs Outsourcing Market Analysis

    ID: MRFR/HC/6334-HCR
    90 Pages
    Kinjoll Dey
    October 2025

    Healthcare Regulatory Affairs Outsourcing Market Research Report Information By Service (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs), By End User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical D...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Healthcare Regulatory Affairs Outsourcing Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Healthcare Regulatory Affairs Outsourcing Market Industry Landscape

    The regulatory affairs outsourcing healthcare market shows a shifting environment caused by several factors that are now shaping its growth and evolution. Social Affairs forms a fundamental pillar of the healthcare sector, guiding the intricate process of legislation, optimizing for compliance, and fast tracking approvals. As a consequence of this the regulatory affairs talent being more and more specialized as well as the product portfolio rising, the most in demand services in outsourcing field are now connected with regulatory affairs. Healthcare companies nowadays have been relying more and more on outsourcing partners to handle global regulatory issues and thereby enable them create their own products within a short span of time.

    The rapid evolution and the bulk of the healthcare sector through the technological advancements worldwide is among the major factors strongly affect the healthcare regulatory affairs outsourcing market dynamics. Through digitization of process of regulation, through implementation of e-submission system and through applying modern analytics, businesses regulation is creating efficiencies. These systems enhance functioning not only at the level of forming a more coordinated response of the companies but also of the government of the country to the challenges which they might face.

    The situation and factors are more complicated which require guidance from specialized expertise and the increase in cost of keeping in-house regulatory affairs unit. With the regulation framework itself changing all the time, there is a need for a good understanding of the regulatory customs nationally and internationally. This is why companies must be able to use their specific knowledge. Outsourcing to regulatory affairs functions could be selling clients the competencies of regulatory experts without having to hire and train all the staff internally. On the other side, the high costs of these processes as a consequence of salaries and need for constant training, the trend toward outsourcing, especially among the small and mid-sized companies, gets intensified.

    Some of the problems within market dynamic are such as security of data, content and possible bottlenecks within regulatory processes. Outsourcing partners hold the responsibility of handling regulatory data inputs from companies, such measure becomes important in giving data security. Partners must ensure quality control and ability to follow timelines for outsourcing processes that is vital to build trust. First of all, the regime of success for outsourcing also will depend on effective communication and team work among companies and their regulatory affairs outsourcing partners who will work together to avoid delays that can accompany this kind of activities.

    Generally, regulatory issues substantially shape health market operation for Healthcare Regulatory Affairs Outsourcing (HRAO). Strict rules and regulations are put in place for the constitution of regulatory functions by outsourcing and data protection regulations too has to be put in place. Customerships must have precise requirements that their outsourcing partners to fulfill by showcasing commitment to this if only the collaboration is going to be seamless. Besides, being ethical and adhering to regulations is imperative to develop trust.

    Market Summary

    As per Market Research Future Analysis, the Global Healthcare Regulatory Affairs Outsourcing Market was valued at USD 6.12 Billion in 2024 and is projected to reach USD 14.55 Billion by 2035, growing at a CAGR of 8.19% from 2025 to 2035. Key drivers include increased R&D efforts, geographic expansion for quicker approvals, and a rise in clinical trial applications. Major players like AmerisourceBergen and Abbott are enhancing their services to navigate regulatory complexities and improve diversity in clinical trials. The Asia Pacific region dominated the market in 2022, accounting for 45.80% of the share, driven by a surge in clinical trials and cost-effective skilled labor.

    Key Market Trends & Highlights

    The market is witnessing significant trends driven by regulatory complexities and the need for compliance.

    • Market Size in 2024: USD 6.12 Billion
    • Projected Market Size by 2035: USD 14.55 Billion
    • CAGR from 2025 to 2035: 8.19%
    • Asia Pacific Market Share in 2022: 45.80%

    Market Size & Forecast

    2024 Market Size USD 6.12 Billion
    2035 Market Size USD 14.55 Billion
    CAGR (2024-2035) 8.19%
    Largest Regional Market Share in 2022 Asia Pacific.

    Major Players

    Accell Clinical Research, LLC; Charles River Laboratories International, Inc.; Clinilabs, Inc.; ICON plc; Covance, Inc.; PAREXEL International Corporation; Pharmaceutical Product Development (PPD) LLC; WuXi App Tec.

    Market Trends

    An increase in geographical expansion activities by companies that aim for speedy approvals in local markets is driving market growth

    The practise of outsourcing regulatory matters has grown in significance within the healthcare sector. The use of outsourcing models for regulatory services is anticipated to be influenced by an increase in geographic expansion initiatives by businesses seeking quick approvals in regional markets. The market for regulatory affairs outsourcing is growing quickly as a result of increased R&D efforts, which is increasing the number of clinical trial applications and product registrations.

    In turn, it is anticipated that the demand for regulatory affairs outsourcing among life science companies will be fueled by an increase in out-of-pocket costs, uneven economic growth, and measures taken by various governments to contain the cost of drugs. Regulatory compliance and product-specific clinical advice and strategy might be crucial for product approval in the early phases of product development. The approval process can be delayed as a result of improperly designed research, manufacturing errors, omitted studies, and other failures to comply with the regulations if regulatory compliance is not addressed in the early stages of development.

    Thus, driving the Healthcare Regulatory Affairs Outsourcing market revenue.

    The increasing complexity of global regulatory requirements is driving healthcare companies to seek outsourcing solutions for regulatory affairs, which may enhance compliance and operational efficiency.

    U.S. Food and Drug Administration (FDA)

    Healthcare Regulatory Affairs Outsourcing Market Market Drivers

    Market Growth Projections

    The Global Healthcare Regulatory Affairs Outsourcing Market Industry is poised for substantial growth, with projections indicating an increase from 6.12 USD Billion in 2024 to 14.6 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 8.2 percent from 2025 to 2035, driven by various factors including regulatory complexity, globalization, and technological advancements. The increasing reliance on outsourcing for regulatory affairs is expected to reshape the industry landscape, as companies seek to enhance compliance and operational efficiency. This upward trend underscores the growing recognition of the strategic importance of regulatory affairs in the healthcare sector.

    Increasing Regulatory Complexity

    The Global Healthcare Regulatory Affairs Outsourcing Market Industry is experiencing a surge in demand due to the increasing complexity of regulatory requirements across various regions. As healthcare regulations evolve, companies face challenges in compliance, necessitating specialized expertise. This complexity is particularly evident in regions like the European Union and the United States, where stringent guidelines govern product approvals. Outsourcing regulatory affairs allows organizations to leverage the expertise of specialized firms, ensuring compliance while focusing on core business activities. This trend is expected to drive the market's growth, contributing to the projected increase from 6.12 USD Billion in 2024 to 14.6 USD Billion by 2035.

    Rising Demand for Clinical Trials

    The rising demand for clinical trials is a significant driver of the Global Healthcare Regulatory Affairs Outsourcing Market Industry. As pharmaceutical and biotechnology companies seek to expedite the development of new therapies, the need for efficient regulatory oversight becomes paramount. Outsourcing regulatory affairs allows these companies to navigate the intricate approval processes associated with clinical trials, ensuring compliance with regulatory standards. This trend is particularly relevant in the context of increasing investment in research and development, which is projected to grow substantially in the coming years. The outsourcing of regulatory affairs is likely to play a crucial role in facilitating the timely execution of clinical trials.

    Globalization of Healthcare Products

    The globalization of healthcare products is a pivotal driver for the Global Healthcare Regulatory Affairs Outsourcing Market Industry. As companies expand their reach into international markets, they encounter diverse regulatory environments that require tailored strategies for compliance. This trend is particularly pronounced in emerging markets, where regulatory frameworks may differ significantly from those in developed regions. Outsourcing regulatory affairs enables organizations to navigate these complexities effectively, ensuring timely market entry and compliance with local regulations. The anticipated growth of the market, from 6.12 USD Billion in 2024 to 14.6 USD Billion by 2035, underscores the importance of adapting to global regulatory demands.

    Cost Efficiency and Resource Optimization

    The Global Healthcare Regulatory Affairs Outsourcing Market Industry is significantly influenced by the need for cost efficiency and resource optimization. By outsourcing regulatory affairs, companies can reduce operational costs associated with hiring and training in-house staff. This approach allows organizations to allocate resources more effectively, focusing on innovation and product development. The financial implications are substantial, as outsourcing can lead to savings of up to 30 percent in regulatory compliance costs. As the market continues to grow, companies are likely to seek outsourcing solutions that enhance their operational efficiency while navigating the complex regulatory landscape.

    Technological Advancements in Regulatory Processes

    Technological advancements are reshaping the landscape of the Global Healthcare Regulatory Affairs Outsourcing Market Industry. Innovations such as artificial intelligence and data analytics are streamlining regulatory processes, enhancing efficiency and accuracy. These technologies facilitate real-time monitoring of regulatory changes, enabling organizations to respond swiftly to evolving requirements. As a result, outsourcing firms that leverage these technologies can offer enhanced services, attracting more clients seeking to optimize their regulatory compliance strategies. The integration of technology is likely to contribute to the market's growth, with a projected CAGR of 8.2 percent from 2025 to 2035.

    Market Segment Insights

    Healthcare Regulatory Affairs Outsourcing Service Insights

    The market segments of Healthcare Regulatory Affairs Outsourcing, based on Service, includes regulatory writing and publishing, regulatory submissions, clinical trial applications and services registrations, regulatory consulting and legal representation, and other regulatory affairs. Clinical trial applications and services registrations segment dominated the market in 2022. The outsourcing trend for clinical trial applications is being driven by an increase in clinical trials worldwide, strict regulations in developed markets, and legal/regulatory improvements in growing areas like the Asia Pacific.

    The market for legal representation services is predicted to increase most quickly. This is a result of the growing demand for legal counsel due to the isation of the pharmaceutical and medical device industries. The laws are extremely intricate and dynamic. The need for local expertise for legal counsel to acquire regulatory clearances and custom clearance increases due to the shifting regulatory landscape in places including Asia Pacific, MEA, and Latin America. These elements are raising demand for legal services all around the world.

    Healthcare Regulatory Affairs Outsourcing End User Insights

    The Healthcare Regulatory Affairs Outsourcing market segmentation, based on End User, includes mid-size pharmaceutical companies, large pharmaceutical companies, biotechnology companies, medical device companies, and food and beverage companies. Large pharmaceutical companies segment dominated the Healthcare Regulatory Affairs Outsourcing market in 2022. Large businesses tend to have long-term relationships with their service providers in order to prevent sudden disruptions in their operations. As a result, they prefer a service provider who can support their varied cross-scale and ramp-up operations while still being able to meet their regulatory obligations.

    In addition, according to a GEP (2020) report, large-scale pharmaceutical businesses often outsource roughly 50% of their regulatory affairs requirements. These elements are assisting in the development of this market sector.

    Figure 1 Healthcare Regulatory Affairs Outsourcing Market, by End User, 2022 & 2032 (USD Billion)

    Source Secondary Research, Primary Research, MRFR Database and Analyst Review

    Get more detailed insights about Healthcare Regulatory Affairs Outsourcing Market Research Report - Forecast till 2032

    Regional Insights

    By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The Asia Pacific Healthcare Regulatory Affairs Outsourcing market dominated this market in 2022 (45.80%). This is related to the increase in clinical trials and the quantity of companies making an effort to enter emerging markets like China and India. The availability of competent personnel in the region at less expensive rates than in the United States is another factor that is projected to fuel the rise of the regional market.

    Moreover, China’s Healthcare Regulatory Affairs Outsourcing market held the largest market share, and the Indian Healthcare Regulatory Affairs Outsourcing market was the fastest growing market in the Asia-Pacific region.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2 HEALTHCARE REGULATORY AFFAIRS OUTSOURCING MARKET SHARE BY REGION 2022 (USD Billion)Healthcare Regulatory Affairs Outsourcing Market

    Source Secondary Research, Primary Research, MRFR Database and Analyst Review

    The North America Healthcare Regulatory Affairs Outsourcing Market is expected to register significant growth from 2024 to 2032. Some of the main reasons propelling the market in North America are the existence of significant pharmaceutical and medical device businesses as well as the increase in R&D spending in the area. Major pharmaceutical companies are outsourcing regulatory affairs tasks as a result of pricing pressure brought on by the shifting reimbursement landscape and generic competition, which is contributing to the expansion of healthcare regulatory outsourcing services in North America.

    Additionally, increased clinical trial numbers and increasing research and development activity foreshadowed the region's market expansion. Additionally, according to Clinicaltrials.gov's November 2021 updated data, 32% of the trials were registered in the United States, with the majority of these trials being dedicated to different sorts of medications, which is likely to drive the regulatory affairs outsourcing and hence predict the market's expansion. Further, the U.S. market of Healthcare Regulatory Affairs Outsourcing held the largest market share, and the Canada market of Healthcare Regulatory Affairs Outsourcing was the fastest growing market in the North America region.

    Europe Healthcare Regulatory Affairs Outsourcing market accounted for the healthy market share in 2022. This is due to the existence of numerous clinical research organisations, the prominence of important actors, the rise in healthcare spending, the volume of R&D&I activities, and the growing adoption of cutting-edge technology. Further, the German market of Healthcare Regulatory Affairs Outsourcing held the largest market share, and the U.K market of Healthcare Regulatory Affairs Outsourcing was the fastest growing market in the European region

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their product lines, which will help the market of Healthcare Regulatory Affairs Outsourcing, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Healthcare Regulatory Affairs Outsourcing Industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Healthcare Regulatory Affairs Outsourcing Industry to benefit clients and increase the market sector. In recent years, the Healthcare Regulatory Affairs Outsourcing Industry has offered some of the most significant advantages to medicine.

    Major players in the Healthcare Regulatory Affairs Outsourcing market, including Accell Clinical Research, LLC, Charles River Laboratories International, Inc., Clinilabs, Inc., Criterium Inc., ICON plc, Covance, Inc., Medpace, Inc., PAREXEL International Corporation, Pharmaceutical Product Development, (PPD) LLC, Promedica International, Quintiles Transnational Corporation, and WuXi App Tec, are attempting to increase market demand by investing in research and development operations.

    The biotechnology, pharmaceutical, and medical device sectors all around the world receive their outsourced development services from the contract research organisation (CRO) ICON Plc (ICON). It offers specialised services that cover every stage of the development of a product. Adaptive trials, biosimilars, clinical research services, commercialization and results, consulting, provision of functional services, medical imaging, resourcing solutions, laboratory services, strategic support, and tactical solutions for conventional, in vitro diagnostic, and software devices are all included in the company's service portfolio.

    The business, among others, provides research services in the fields of cancer, genomics, the central nervous system, the gastrointestinal tract, medical devices, non-alcoholic steatohepatitis (NASH), rare and orphan diseases, transplant and immunology, vaccines, and women's health. ICON's main office is in Dublin, Ireland. ICON plc bought PRA Health Sciences, Inc. in February 2021 for a total transaction value of US $12 billion in cash and equity. The company's service offering for medical affairs has been strengthened as a result of this purchase.

    ProPharma Group offers pharmacovigilance, compliance consultancy, and medical information services. From clinical to commercialization and anywhere in between, the business provides customers in the pharmaceutical, biotechnology, and medical device industries with compliance, quality assurance, and consulting services. It collaborates with its clients to ensure that regulatory requirements are met, corporate objectives are met, and patient safety is safeguarded. ProPharma Group purchased iSafety Systems, which was situated in India, in August 2021. ProPharma Group's position as the leading provider of regulatory and compliance consultancy, pharmacovigilance, clinical research services, and medical information will be strengthened as a result of this transaction.

    Key Companies in the Healthcare Regulatory Affairs Outsourcing Market market include

    Industry Developments

    April 2021 A strategic agreement between Veeva Systems and Parexel was announced with the goal of accelerating clinical trials through the use of new technology. Both companies will gain from the regulatory consultancy services of the other.

    July 2021 To broaden its DCT products into international markets and satisfy the rising need for patient-centric trial designs, Covance acquired Care, a  leader in patient-centric decentralised clinical trials (DCTs).

    Future Outlook

    Healthcare Regulatory Affairs Outsourcing Market Future Outlook

    The Healthcare Regulatory Affairs Outsourcing Market is projected to grow at an 8.19% CAGR from 2024 to 2032, driven by increasing regulatory complexities and demand for compliance expertise.

    New opportunities lie in:

    • Leverage AI technologies to streamline regulatory submission processes and enhance accuracy.
    • Expand service offerings to include post-market surveillance and risk management solutions.
    • Form strategic partnerships with emerging biotech firms to provide tailored regulatory guidance.

    By 2035, the market is expected to be robust, reflecting a dynamic landscape of regulatory outsourcing solutions.

    Market Segmentation

    Healthcare Regulatory Affairs Outsourcing Service Outlook

    • Regulatory Writing and Publishing
    • Regulatory Submissions
    • Clinical Trial Applications and Services Registrations
    • Regulatory Consulting and Legal Representation
    • Other Regulatory Affairs

    Healthcare Regulatory Affairs Outsourcing End User Outlook

    • Mid-Size Pharmaceutical Companies
    • Large Pharmaceutical Companies
    • Biotechnology Companies
    • Medical Device Companies
    • Food and Beverage Companies

    Healthcare Regulatory Affairs Outsourcing Regional Outlook

    • US
    • Canada

    Report Scope

    Healthcare Regulatory Affairs Outsourcing Report Scope

    Report Attribute/Metric Details
    Market Size 2024 USD 6.12 Billion
    Market Size 2035 14.55 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR) 8.19% (2025 - 2035)
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2018-2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Service, End User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Accell Clinical Research, LLC, Charles River Laboratories International, Inc., Clinilabs, Inc., Criterium Inc., ICON plc, Covance, Inc., Medpace, Inc., PAREXEL International Corporation, Pharmaceutical Product Development, (PPD) LLC, Promedica International, Quintiles Transnational Corporation, and WuXi App Tec
    Key Market Opportunities Economic growth in emerging market
    Key Market Dynamics An increase in geographical expansion activities by companies that aim for speedy approvals in local markets, the increase in R&D activities, and augmenting the volume of clinical trial applications and product registrations
    Market Size 2025 6.62 (Value (USD Billion))

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the projected growth of the Healthcare Regulatory Affairs Outsourcing market?

    The Healthcare Regulatory Affairs Outsourcing market is the expected increase in total market value of 14.55 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Healthcare Regulatory Affairs Outsourcing market?

    Healthcare Regulatory Affairs Outsourcing market size was valued at approximately 6.12 billion USD in 2024. This figure will reach 14.55 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Healthcare Regulatory Affairs Outsourcing market?

    Healthcare Regulatory Affairs Outsourcing market is expected to grow at a CAGR of 8.19% between 2025 and 2035.

    How much will the Healthcare Regulatory Affairs Outsourcing market be worth by 2035?

    Healthcare Regulatory Affairs Outsourcing market is expected to be worth of 14.55 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Healthcare Regulatory Affairs Outsourcing market perform over the next 10 years?

    Over the next 10 years the Healthcare Regulatory Affairs Outsourcing market is expected to shift from usd billion 6.12 to 14.55 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the Healthcare Regulatory Affairs Outsourcing market?

    Asia Pacific had the largest share in the market

    1. Table of Content:
    2. Chapter 1. Report Prologue
    3. Chapter 2. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Chapter 3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Chapter 4. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Detection Technique Trends & Assessment
    6. Chapter 5. Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Chapter 6. Global Healthcare Regulatory Affairs Outsourcing Market, by Service
      1. Introduction
      2. Regulatory Writing and Publishing
    8. Market Estimates & Forecast, by Region, 2023-2032
    9. Market Estimates & Forecast, by Country, 2023-2032
      1. Regulatory Submissions
    10. Market Estimates & Forecast, by Region, 2023-2032
    11. Market Estimates & Forecast, by Country, 2023-2032
      1. Clinical Trial Applications and Service Registrations
    12. Market Estimates & Forecast, by Region, 2023-2032
      1. Regulatory Consulting and Legal Representation
      2. Other Regulatory Affairs
    13. Chapter 7. Global Healthcare Regulatory Affairs Outsourcing Market, by End User
      1. Introduction
      2. Mid-Size Pharmaceutical Companies
    14. Market Estimates & Forecast, by Region, 2023-2032
      1. Large Pharmaceutical Companies
    15. Market Estimates & Forecast, by Country, 2023-2032
      1. Biotechnology Companies
    16. Market Estimates & Forecast, by Country, 2023-2032
      1. Medical Device Companies
      2. Food and Beverage Companies
    17. Chapter 8. Global Healthcare Regulatory Affairs Outsourcing Market, by Region
      1. Introduction
      2. Americas
        1. North America
        2. Latin America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      5. Middle East & Africa
        1. Middle East
        2. Africa
    18. Chapter 9. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
    19. Chapter 10. Company Profiles
      1. Accell Clinical Research, LLC
        1. Company Overview
        2. Treatment Overview
        3. Financials Overview
        4. Key Developments
        5. SWOT Analysis
      2. Charles River Laboratories International, Inc.
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Clinilabs, Inc.
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Covance, Inc.
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. Criterium, Inc.
        1. Company Overview
        2. Treatment Overview
        3. Financial overview
        4. Key Developments
        5. SWOT Analysis
      6. ICON plc
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      7. Medpace, Inc.
        1. Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      8. PAREXEL International Corporation
        1. Overview
        2. Treatment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Pharmaceutical Product Development, (PPD) LLC
        1. Overview
        2. Treatment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      10. Promedica International
        1. Overview
        2. Treatment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      11. Quintiles Transnational Corporation
        1. Overview
        2. Treatment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      12. WuXi App Tec
        1. Overview
        2. Treatment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
    20. Chapter 11 MRFR Conclusion
      1. Key Findings
        1. From CEO’s Viewpoint
        2. Unmet Needs of the Market
      2. Key Companies to Watch
      3. Predictions for the Regulatory Affairs Outsourcing Industry
    21. Chapter 12. Appendix
    22. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1 Global Healthcare Regulatory Affairs Outsourcing Market Synopsis, 2023-2032
      3. Table 2 Global Healthcare Regulatory Affairs Outsourcing Market Estimates and Forecast, 2023-2032 (USD Million)
      4. Table 3 Global Healthcare Regulatory Affairs Outsourcing Market, by Region, 2023-2032 (USD Million)
      5. Table 4 Global Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      6. Table 5 Global Healthcare Regulatory Affairs Outsourcing Market, by End User, 2023-2032 (USD Million)
      7. Table 6 North America: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      8. Table 7 North America: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2023-2032 (USD Million)
      9. Table 8 US: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      10. Table 9 US: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2023-2032 (USD Million)
      11. Table 10 Canada: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      12. Table 11 Canada: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2023-2032 (USD Million)
      13. Table 12 Latin America: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      14. Table 13 Latin America: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2020– 2027 (USD Million)
      15. Table 14 Europe: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      16. Table 15 Europe: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2023-2032 (USD Million)
      17. Table 16 Western Europe: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      18. Table 17 Western Europe: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2020– 2027 (USD Million)
      19. Table 18 Eastern Europe: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      20. Table 19 Eastern Europe: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2020– 2027 (USD Million)
      21. Table 20 Asia-Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      22. Table 21 Asia-Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2023-2032 (USD Million)
      23. Table 22 Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market, by Service, 2023-2032 (USD Million)
      24. Table 23 Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2023-2032 (USD Million) LIST OF FIGURES
      25. Figure 1 Research Process
      26. Figure 2 Segmentation for Global Healthcare Regulatory Affairs Outsourcing Market
      27. Figure 3 Segmentation Market Dynamics for Global Healthcare Regulatory Affairs Outsourcing Market
      28. Figure 4 Global Healthcare Regulatory Affairs Outsourcing Market Share, by Service, 2020
      29. Figure 5 Global Healthcare Regulatory Affairs Outsourcing Market Share, by End User, 2020
      30. Figure 6 Global Healthcare Regulatory Affairs Outsourcing Market Share, by Region, 2020
      31. Figure 7 North America: Healthcare Regulatory Affairs Outsourcing Market Share, by Country, 2020
      32. Figure 8 Europe: Healthcare Regulatory Affairs Outsourcing Market Share, by Country, 2020
      33. Figure 9 Asia-Pacific: Healthcare Regulatory Affairs Outsourcing Market Share, by Country, 2020
      34. Figure 10 Middle East & Africa: Healthcare Regulatory Affairs Outsourcing Market Share, by Country, 2020
      35. Figure 11 Global Healthcare Regulatory Affairs Outsourcing Market: Company Share Analysis, 2020 (%)
      36. Figure 12 Accell Clinical Research, LLC: Key Financials
      37. Figure 13 Accell Clinical Research, LLC: Segmental Revenue
      38. Figure 14 Accell Clinical Research, LLC: Geographical Revenue
      39. Figure 15 Charles River Laboratories International, Inc.: Key Financials
      40. Figure 16 Charles River Laboratories International, Inc.: Segmental Revenue
      41. Figure 17 Charles River Laboratories International, Inc.: Geographical Revenue
      42. Figure 18 Clinilabs, Inc.: Key Financials
      43. Figure 19 Clinilabs, Inc.: Segmental Revenue
      44. Figure 20 Clinilabs, Inc.: Geographical Revenue
      45. Figure 21 Covance, Inc.: Key Financials
      46. Figure 22 Covance, Inc.: Segmental Revenue
      47. Figure 23 Covance, Inc.: Geographical Revenue
      48. Figure 24 Criterium, Inc.: Key Financials
      49. Figure 25 Criterium, Inc.: Segmental Revenue
      50. Figure 26 Criterium, Inc.: Geographical Revenue
      51. Figure 27 ICON plc: Key Financials
      52. Figure 28 ICON plc: Segmental Revenue
      53. Figure 29 ICON plc: Geographical Revenue
      54. Figure 30 Medpace, Inc.: Key Financials
      55. Figure 31 Medpace, Inc.: Segmental Revenue
      56. Figure 32 Medpace, Inc.: Geographical Revenue
      57. Figure 33 PAREXEL International Corporation: Key Financials
      58. Figure 34 PAREXEL International Corporation: Segmental Revenue
      59. Figure 35 PAREXEL International Corporation: Geographical Revenue
      60. Figure 36 Pharmaceutical Product Development, (PPD) LLC: Key Financials
      61. Figure 37 Pharmaceutical Product Development, (PPD) LLC: Segmental Revenue
      62. Figure 38 Pharmaceutical Product Development, (PPD) LLC: Geographical Revenue
      63. Figure 39 Promedica International: Key Financials
      64. Figure 40 Promedica International: Segmental Revenue
      65. Figure 41 Promedica International: Geographical Revenue
      66. Figure 42 Quintiles Transnational Corporation: Key Financials
      67. Figure 43 Quintiles Transnational Corporation: Segmental Revenue
      68. Figure 44 Quintiles Transnational Corporation: Geographical Revenue
      69. Figure 45 WuXi App Tec: Key Financials
      70. Figure 46 WuXi App Tec: Segmental Revenue
      71. Figure 47 WuXi App Tec: Geographical Revenue

    Healthcare Regulatory Affairs Outsourcing Market Segmentation

    Healthcare Regulatory Affairs Outsourcing Service Outlook (USD Billion, 2018-2032)

    • Regulatory writing And publishing
    • Regulatory Submission
    • Clinical Trial applications and services registrations
    • Regulatory consulting and legal representation
    • Others regulatory affairs

    Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

    • Mid size pharmaceutical companies
    • Large pharmaceutical companies
    • Biotechnology companies
    • Medical device companies
    • Food and beverage companies

    Healthcare Regulatory Affairs Outsourcing Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • US Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Canada Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
    • Europe Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Germany Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • France Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • UK Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Italy Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Spain Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • China Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Japan Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • India Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Australia Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Middle East Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Africa Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
      • Latin America Outlook (USD Billion, 2018-2032)

      • Healthcare Regulatory Affairs Outsourcing by Service
        • Regulatory writing And publishing
        • Regulatory Submission
        • Clinical Trial applications and services registrations
        • Regulatory consulting and legal representation
        • Others regulatory affairs
      • Healthcare Regulatory Affairs Outsourcing End-user Outlook (USD Billion, 2018-2032)

        • Mid size pharmaceutical companies
        • Large pharmaceutical companies
        • Biotechnology companies
        • Medical device companies
        • Food and beverage companies
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials